Evidence map›Paper›PMID 18668563›Full record

ArticleArthritis and rheumatism2008

The arthritis severity locus Cia5d is a novel genetic regulator of the invasive properties of synovial fibroblasts.

Teresina Laragione, Max Brenner, Adriana Mello, Marc Symons, Pércio S Gulko

Abstract read
In one paragraph

Article in Arthritis and rheumatism, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Teresina LaragioneFeinstein Institute for Medical Research, Manhasset, NY 11030, USA.
Max Brenner
Adriana Mello
Marc Symons
Pércio S Gulko
Feinstein Institute for Medical Research · USNew York University · US

Funding

IDENTIFICATION OF GENES REGULATING ARTHRITIS IN RATSR01AR046213 · NIAMS · NORTH SHORE UNIVERSITY HOSPITAL · PI GULKO, PERCIO S · 1999 to 2011
$2.6M
Identification of arthritis genes in DAxF344 congenic rats.R01AR052439 · NIAMS · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI GULKO, PERCIO S · 2005 to 2009
$1.7M
Identification of a gender-specific rat arthritis locusR01AI054348 · NIAID · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI GULKO, PERCIO S. · 2002 to 2005
$1.2M
NIAID NIH HHS R01 AI054348NIAID NIH HHS R01 AI 54348NIAMS NIH HHS R01 AR046213NIAMS NIH HHS R01 AR 052439NIAMS NIH HHS R01 AR052439NIAMS NIH HHS R01 AR 46213
6 · The paper itself

Abstract

objectiveThe synovial fibroblast, or fibroblast-like synoviocyte (FLS), has a central role in pannus invasion and destruction of cartilage and bone in rheumatoid arthritis (RA). However, regulation of the FLS remains incompletely understood. The aim of this study was to determine whether the invasive properties of FLS are genetically regulated by arthritis severity loci.

methodsDA rats (arthritis susceptible) and rat strains congenic for arthritis-protective intervals were studied. Primary FLS cell lines were generated from each strain and used in a well-established FLS invasion model through a collagen-rich barrier. Cells or culture supernatants were analyzed for gene expression, activity of different matrix metalloproteinases (MMPs), cytoskeleton integrity, and cell proliferation.

resultsThe median number of FLS from DA.F344(Cia5d) rats that invaded through the collagen-rich barrier was reduced 86.5% compared with the median number of invading FLS from DA rats. Histologic examination showed that DA.F344(Cia5d) rats preserved a normal joint without pannus, hyperplasia, or erosions. FLS from DA.F344(Cia5d) rats produced significantly lower levels of active MMP-2 compared with FLS from DA rats, but the levels of proMMP-2 and MMP-2 messenger RNA in DA.F344(Cia5d) rats were similar to those in DA rats. Treatment of FLS from DA rats with an MMP-2 inhibitor reduced cell invasion to a level similar to that in DA.F344(Cia5d) rats, demonstrating that MMP-2 activity accounted for the difference between FLS from these 2 strains. Analysis of MMP-2-activating pathways revealed increased levels of soluble membrane type 1 (MT1)-MMP in DA rats compared with DA.F344(Cia5d) rats.

conclusionThese data represent the first evidence for a genetic component in the regulation of FLS invasion. A gene located within the Cia5d interval accounts for this effect and operates via the regulation of soluble MT1-MMP production and MMP-2 activation. These observations suggest novel potential pathways for prognostication and therapy.

Indexed as

Severity of Illness IndexActinsAnimalsArthritisCell MovementCell ProliferationDisease Models, AnimalFibroblastsMatrix Metalloproteinase 14Matrix Metalloproteinase 2Matrix Metalloproteinase 3Quantitative Trait LociRatsRats, Inbred ACIRats, Inbred F344Rats, Inbred StrainsActinsMatrix Metalloproteinase 14Matrix Metalloproteinase 2Matrix Metalloproteinase 3RNA, MessengerTissue Inhibitor of Metalloproteinase-2Tissue Plasminogen ActivatorUrokinase-Type Plasminogen Activator

Identifiers

PMID18668563
PMCPMC2714698
OpenAlexW2067451867

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.